Tag Archives: targeted antithrombin drug

European Society of Cardiology congress 2018, held in Munich This was the key finding from COMMANDER HF (A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction, or Stroke in Participants with Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure) presented in a Hot Line Session and also published in The New England Journal of Medicine (DOI: 10.1056/NEJMoa1808848). Patients with worsening heart failure experience high rates of hospital readmission, and death. Previous studies have suggested that the enzyme thrombin may contribute to these poor o